UK pharmaceutical giant AstraZeneca PLC on Friday said that it was abandoning plans to build a £450 million (US$557.5 million) vaccine plant, a major blow to the Labour Party government’s plans to revive a sluggish economy.
“Following protracted discussions with the government, we are no longer pursuing our planned investment” for Speke in Liverpool, northwest England, a company spokesperson said.
The company cited “timing” issues and a “reduction” in the public subsidies offered by the Labour government compared with its Conservative predecessor.
Photo: REUTERS
A source close to the issue said that British Prime Minister Keir Starmer’s government, elected in July last year, was proposing £40 million in subsidies compared with the £90 million offered previously.
A government spokesperson said that “a change in the make-up of the investment originally proposed by AstraZeneca led to a reduced government grant offer being put forward.”
“All government grant funding has to demonstrate value for the taxpayer and unfortunately, despite extensive work from government officials, it has not been possible to achieve a solution,” the spokesperson added.
The group already has a factory on the site, which would not be affected by the decision and would continue to produce flu vaccines.
The UK government did not immediately respond when asked for comment.
However, media reports called it a snub to British Chancellor of the Exchequer Rachel Reeves, who has tried in recent weeks to reassure companies worried about tax rises on employers announced at the end of October last year.
Reeves, who has said for months that growth is her priority, on Wednesday outlined a recovery plan whose flagship measure was the government’s approval of a third runway at Heathrow, the largest airport in the UK and Europe.
She also announced relaxations of planning rules and deregulation measures to boost investment, as well as backing several investment projects to make the Oxford-Cambridge axis a “European Silicon Valley.”
Having already stalled in the third quarter and then fallen in October, the UK’s GDP rebounded by a less-than-expected 0.1 percent in November last year. However, the IMF mid last month revised upward its growth forecast for the country this year to 1.6 percent.
The Society of Chemical Industry called AstraZeneca’s decision a “real concern for industry,” because it sent “out the wrong message at a time government is shaping its new industrial strategy.”
“If life sciences are going to be a major pillar of the UK’s new industrial strategy, then the UK needs to make some bold steps forward to ensure it is competitive for life sciences investments,” said the society’s chief executive, Sharon Todd.
Three experts in the high technology industry have said that US President Donald Trump’s pledge to impose higher tariffs on Taiwanese semiconductors is part of an effort to force Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) to the negotiating table. In a speech to Republicans on Jan. 27, Trump said he intends to impose tariffs on Taiwan to bring chip production to the US. “The incentive is going to be they’re not going to want to pay a 25, 50 or even a 100 percent tax,” he said. Darson Chiu (邱達生), an economics professor at Taichung-based Tunghai University and director-general of
Hon Hai Precision Industry Co (鴻海精密) is reportedly making another pass at Nissan Motor Co, as the Japanese automaker's tie-up with Honda Motor Co falls apart. Nissan shares rose as much as 6 percent after Taiwan’s Central News Agency reported that Hon Hai chairman Young Liu (劉揚偉) instructed former Nissan executive Jun Seki to connect with French carmaker Renault SA, which holds about 36 percent of Nissan’s stock. Hon Hai, the Taiwanese iPhone-maker also known as Foxconn Technology Group (富士康科技集團), was exploring an investment or buyout of Nissan last year, but backed off in December after the Japanese carmaker penned a deal
WASHINGTON POLICY: Tariffs of 10 percent or more and other new costs are tipped to hit shipments of small parcels, cutting export growth by 1.3 percentage points The decision by US President Donald Trump to ban Chinese companies from using a US tariff loophole would hit tens of billions of dollars of trade and reduce China’s economic growth this year, according to new estimates by economists at Nomura Holdings Inc. According to Nomura’s estimates, last year companies such as Shein (希音) and PDD Holdings Inc’s (拼多多控股) Temu shipped US$46 billion of small parcels to the US to take advantage of the rule that allows items with a declared value under US$800 to enter the US tariff-free. Tariffs of 10 percent or more and other new costs would slash such
SENSOR BUSINESS: The Taiwanese company said that a public tender offer would begin on May 7 through its wholly owned subsidiary Yageo Electronics Japan Yageo Corp (國巨), one of the world’s top three suppliers of passive components, yesterday said it is to launch a tender offer to fully acquire Japan’s Shibaura Electronics Co for up to ¥65.57 billion (US$429.37 million), with an aim to expand its sensor business. The tender offer would be a crucial step for the company to expand its sensor business, Yageo said. Shibaura Electronics is the world’s largest supplier of thermistors, with a market share of 13 percent, research conducted in 2022 by the Japanese firm showed. If a deal goes ahead, it would be the second acquisition of a sensor business since